Publicaciones en colaboración con investigadores/as de Hospital de Jerez (162)

2024

  1. Clinicopathological and Genomic Identification of Breast Cancers with No Impact on Mortality

    Cancers, Vol. 16, Núm. 6

  2. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Asociación entre tabaco y uveítis

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 2, pp. 63-64

  2. Correction: Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study (Annals of Clinical Microbiology and Antimicrobials, (2023), 22, 1, (90), 10.1186/s12941-023-00626-7)

    Annals of Clinical Microbiology and Antimicrobials

  3. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology

  4. Implicación ocular en el tratamiento con radiofrecuencia pulsada del ganglio esfenopalatino

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 9, pp. 544-547

  5. Latest developments in early diagnosis and specific treatment of severe influenza infection

    Journal of Intensive Medicine

  6. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  7. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain

    European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490

  8. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

2022

  1. ADENI-UCI Study: Analysis of non-income decisions in ICU as a measure of limitation of life support treatments

    Medicina Intensiva, Vol. 46, Núm. 4, pp. 192-200

  2. Early recruitable coronary collaterals preserve miocardial viability in late presentation infarctions

    Coronary Artery Disease, Vol. 33, Núm. 6, pp. 433-439

  3. Global Comparison of Communication of End-of-Life Decisions in the ICU

    Chest, Vol. 162, Núm. 5, pp. 1074-1085

  4. Host response dysregulations amongst adults hospitalized by influenza A H1N1 virus pneumonia: A prospective multicenter cohort study

    European Journal of Internal Medicine, Vol. 104, pp. 89-97

  5. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

    International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392

  6. Impact of Systemic Comorbidities on Ocular Hypertension and Open-Angle Glaucoma, in a Population from Spain and Portugal

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  7. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

  8. Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department

    Journal of Personalized Medicine, Vol. 12, Núm. 1

  9. Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza

    Medicina Intensiva, Vol. 46, Núm. 8, pp. 436-445

2021

  1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535